GLI Pathogenesis-Related 1 (GLIPR1) Peptide
GLIPR1
Reactivité: Humain
Hôte: Synthetic
BP, Imm
-
- Antigène Tous les produits GLIPR1
- GLIPR1 (GLI Pathogenesis-Related 1 (GLIPR1))
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Séquence
- NRQRDQVKRY YS
- Attributs du produit
- The peptide was used in the production of ABIN369505 - Goat Anti-GLIPR1 / RTVP-1 Antibody. It is currently untested in blocking applications.
-
-
- Indications d'application
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Stock
- -20 °C
- Stockage commentaire
- Shipped at ambient temperature, store at -20°C.
-
- Antigène
- GLIPR1 (GLI Pathogenesis-Related 1 (GLIPR1))
- Synonymes
- CRISP7 Peptide, GLIPR Peptide, RTVP1 Peptide, 2410114O14Rik Peptide, RTVP-1 Peptide, mRTVP-1 Peptide, GLIPR1 Peptide, zgc:65887 Peptide, GLI pathogenesis related 1 Peptide, GLI pathogenesis-related 1 Peptide, GLI pathogenesis-related 1 (glioma) Peptide, GLI pathogenesis-related 1b Peptide, GLIPR1 Peptide, Glipr1 Peptide, glipr1b Peptide
-
Vous êtes ici:
